
Mary M. Lyons
Examiner (ID: 13723, Phone: (571)272-2966 , Office: P/1645 )
| Most Active Art Unit | 1645 |
| Art Unit(s) | 1653, 1645 |
| Total Applications | 674 |
| Issued Applications | 374 |
| Pending Applications | 93 |
| Abandoned Applications | 228 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17385978
[patent_doc_number] => 20220033830
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-03
[patent_title] => FUNCTIONALIZATION OF ENDOGENOUS BACTERIA
[patent_app_type] => utility
[patent_app_number] => 17/189113
[patent_app_country] => US
[patent_app_date] => 2021-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15901
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17189113
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/189113 | FUNCTIONALIZATION OF ENDOGENOUS BACTERIA | Feb 28, 2021 | Pending |
Array
(
[id] => 18391689
[patent_doc_number] => 20230159907
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-25
[patent_title] => PERFORMANCE-ENHANCED PROTEASE VARIANTS VII
[patent_app_type] => utility
[patent_app_number] => 17/908554
[patent_app_country] => US
[patent_app_date] => 2021-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11101
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17908554
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/908554 | PERFORMANCE-ENHANCED PROTEASE VARIANTS VII | Feb 24, 2021 | Pending |
Array
(
[id] => 18685384
[patent_doc_number] => 11781107
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-10-10
[patent_title] => Microorganisms engineered for muconate production
[patent_app_type] => utility
[patent_app_number] => 17/184580
[patent_app_country] => US
[patent_app_date] => 2021-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 8681
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17184580
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/184580 | Microorganisms engineered for muconate production | Feb 23, 2021 | Issued |
Array
(
[id] => 17065880
[patent_doc_number] => 20210268095
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-02
[patent_title] => ESCHERICHIA COLI COMPOSITIONS AND METHODS THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/180959
[patent_app_country] => US
[patent_app_date] => 2021-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 88355
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17180959
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/180959 | ESCHERICHIA COLI COMPOSITIONS AND METHODS THEREOF | Feb 21, 2021 | Abandoned |
Array
(
[id] => 18266021
[patent_doc_number] => 20230087263
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-23
[patent_title] => ANTI-CD19/ANTI-CD3 BISPECIFIC ANTIBODY, T CELLS SECRETING THE SAME, METHOD OF PREPARATION AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/800032
[patent_app_country] => US
[patent_app_date] => 2021-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14090
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17800032
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/800032 | Anti-CD19/anti-CD3 bispecific antibody, T cells secreting the same, method of preparation and use thereof | Feb 15, 2021 | Issued |
Array
(
[id] => 17792532
[patent_doc_number] => 20220251623
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-11
[patent_title] => Method and apparatus for avoiding false positive coliform testing
[patent_app_type] => utility
[patent_app_number] => 17/300020
[patent_app_country] => US
[patent_app_date] => 2021-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1477
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17300020
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/300020 | Method and apparatus for avoiding false positive coliform testing | Feb 8, 2021 | Abandoned |
Array
(
[id] => 17649941
[patent_doc_number] => 11352655
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-06-07
[patent_title] => Method of identification of methicillin-resistant
[patent_app_type] => utility
[patent_app_number] => 17/170912
[patent_app_country] => US
[patent_app_date] => 2021-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 22
[patent_no_of_words] => 4914
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17170912
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/170912 | Method of identification of methicillin-resistant | Feb 8, 2021 | Issued |
Array
(
[id] => 18452056
[patent_doc_number] => 20230193335
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-22
[patent_title] => HMO PRODUCTION
[patent_app_type] => utility
[patent_app_number] => 17/759270
[patent_app_country] => US
[patent_app_date] => 2021-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11965
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17759270
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/759270 | HMO PRODUCTION | Jan 21, 2021 | Pending |
Array
(
[id] => 16822764
[patent_doc_number] => 20210138057
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-13
[patent_title] => Anti-Microbial Immunomodulation
[patent_app_type] => utility
[patent_app_number] => 17/154536
[patent_app_country] => US
[patent_app_date] => 2021-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35767
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17154536
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/154536 | Anti-microbial immunomodulation | Jan 20, 2021 | Issued |
Array
(
[id] => 18780187
[patent_doc_number] => 11821898
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-11-21
[patent_title] => Rapid test for Lyme bacteria
[patent_app_type] => utility
[patent_app_number] => 17/152146
[patent_app_country] => US
[patent_app_date] => 2021-01-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 5537
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 286
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17152146
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/152146 | Rapid test for Lyme bacteria | Jan 18, 2021 | Issued |
Array
(
[id] => 18196706
[patent_doc_number] => 20230050225
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-16
[patent_title] => Vaccines targeting Neisseria gonorrhoeae
[patent_app_type] => utility
[patent_app_number] => 17/791038
[patent_app_country] => US
[patent_app_date] => 2021-01-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 47713
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17791038
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/791038 | Vaccines targeting Neisseria gonorrhoeae | Jan 5, 2021 | Pending |
Array
(
[id] => 18504859
[patent_doc_number] => 11702664
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-07-18
[patent_title] => Listeria-based compositions comprising a peptide minigene expression system and methods of use thereof
[patent_app_type] => utility
[patent_app_number] => 17/127530
[patent_app_country] => US
[patent_app_date] => 2020-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 33
[patent_no_of_words] => 42815
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 126
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17127530
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/127530 | Listeria-based compositions comprising a peptide minigene expression system and methods of use thereof | Dec 17, 2020 | Issued |
Array
(
[id] => 18126519
[patent_doc_number] => 20230012140
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-12
[patent_title] => ORAL RESPIRATORY VACCINE
[patent_app_type] => utility
[patent_app_number] => 17/783228
[patent_app_country] => US
[patent_app_date] => 2020-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10476
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17783228
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/783228 | ORAL RESPIRATORY VACCINE | Dec 16, 2020 | Pending |
Array
(
[id] => 16791738
[patent_doc_number] => 20210121555
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-29
[patent_title] => STREPTOCOCCUS PNEUMONIAE CAPSULAR POLYSACCHARIDES AND CONJUGATES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/125555
[patent_app_country] => US
[patent_app_date] => 2020-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17339
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17125555
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/125555 | STREPTOCOCCUS PNEUMONIAE CAPSULAR POLYSACCHARIDES AND CONJUGATES THEREOF | Dec 16, 2020 | Pending |
Array
(
[id] => 18180482
[patent_doc_number] => 20230041211
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-09
[patent_title] => DECREASING TOXICITY OF TERPENES AND INCREASING THE PRODUCTION POTENTIAL IN MICRO-ORGANISMS
[patent_app_type] => utility
[patent_app_number] => 17/786127
[patent_app_country] => US
[patent_app_date] => 2020-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27181
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17786127
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/786127 | DECREASING TOXICITY OF TERPENES AND INCREASING THE PRODUCTION POTENTIAL IN MICRO-ORGANISMS | Dec 14, 2020 | Pending |
Array
(
[id] => 17198674
[patent_doc_number] => 20210338768
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-04
[patent_title] => COMPOSITION COMPRISING OIL DROPS
[patent_app_type] => utility
[patent_app_number] => 17/118391
[patent_app_country] => US
[patent_app_date] => 2020-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36727
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17118391
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/118391 | COMPOSITION COMPRISING OIL DROPS | Dec 9, 2020 | Abandoned |
Array
(
[id] => 18064477
[patent_doc_number] => 20220395564
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-15
[patent_title] => COMPOSITIONS AND METHODS FOR THE PROPHYLAXIS AND TREATMENT OF BABESIOSIS
[patent_app_type] => utility
[patent_app_number] => 17/779633
[patent_app_country] => US
[patent_app_date] => 2020-11-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25888
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -44
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17779633
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/779633 | COMPOSITIONS AND METHODS FOR THE PROPHYLAXIS AND TREATMENT OF BABESIOSIS | Nov 24, 2020 | Pending |
Array
(
[id] => 17123541
[patent_doc_number] => 20210298309
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-30
[patent_title] => NOVEL PROTECTIVE BARRIER COMPOSITIONS, AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/103392
[patent_app_country] => US
[patent_app_date] => 2020-11-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15149
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17103392
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/103392 | Protective barrier compositions and uses thereof | Nov 23, 2020 | Issued |
Array
(
[id] => 16726535
[patent_doc_number] => 20210093682
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-01
[patent_title] => Lactobacillus Gasseri KBL697 Strain and Use Thereof
[patent_app_type] => utility
[patent_app_number] => 17/102301
[patent_app_country] => US
[patent_app_date] => 2020-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12563
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17102301
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/102301 | None | Nov 22, 2020 | Issued |
Array
(
[id] => 18215264
[patent_doc_number] => 11590177
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-02-28
[patent_title] => Methods of treating cancer using bacteria expressing c-di-AMP
[patent_app_type] => utility
[patent_app_number] => 16/953162
[patent_app_country] => US
[patent_app_date] => 2020-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 70
[patent_no_of_words] => 7754
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16953162
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/953162 | Methods of treating cancer using bacteria expressing c-di-AMP | Nov 18, 2020 | Issued |